Home/Pipeline/Bi‑valent Human Monoclonal Antibody for Rabies

Bi‑valent Human Monoclonal Antibody for Rabies

Human Rabies Post‑Exposure Prophylaxis

Phase 1Active

Key Facts

Indication
Human Rabies Post‑Exposure Prophylaxis
Phase
Phase 1
Status
Active
Company

About Indian Immunologicals

India's top veterinary and human vaccine maker with a global export footprint.

View full company profile

Therapeutic Areas